Latest News

View All Recent News »

Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results

July 30, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter fiscal year 2015...

Read More »

Alimera Sciences Signs Knight Therapeutics As Exclusive ILUVIEN® Distributor For Canada

July 21, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has signed an exclusive agreement...

Read More »

Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference

June 29, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, Chief Operating Officer and Chief...

Read More »